Sector: health
Conviction from: NASDAQCitrini
52-week range: 19.4295.49
RNAi therapeutics drug developer
3 tracked filer(s) hold this · 0 opened, 1 added, 2 trimmed in 30-JUN-2026
Aggregate 13FScore 71 — mean of 3 scored holder(s) · buyers (new/add) avg 63. Higher = the smart money in this name has the better track record.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|
| Paul Tudor Jones / Tudor | 63 | Added +55% | 15,000 | $1,222,650 | 0.0% |
| Howard Marks / Oaktree | 70 | Trimmed -17% | 9,146,000 | $10,951,820 | 0.2% |
| Steve Cohen / Point72 | 80 | Trimmed -14% | 39,900 | $3,252,249 | 0.0% |
Beyond 13F — activists, insiders, politicians & research
1 disclosed trade(s) by 1 filer(s).
| Report | Date | Stance |
|---|
| #97 — Rough Seas Make Strong Sailors: Navigating the Healthcare Policy Tsunami | 2025-05-28 | LONG |